COVID-19 and diabetes management: What should be considered?

标题

作者

关键词

Cardiovascular disease, COVID-19, Diabetes, DPP4, GLP-1RA, Pioglitazone, Hydroxychloroquine, SGLT-2

出版物

Volume 163, Issue -, Pages 108151

出版商

Elsevier BV

发表日期

2020-04-17

DOI

10.1016/j.diabres.2020.108151

联系作者

Discuss science. Find collaborators. Network.

Join a conversation

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started